Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin (Q42992590)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 May 2013

Language	Label	Description	Also known as
English	Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin	scientific article published on 26 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

K. Rajender Reddy

16

object named as

K Rajender Reddy

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

object named as

M S Sulkowski

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

S C Gordon

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

E M Yoshida

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

E J Lawitz

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

B R Bacon

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M Davis

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

F Poordad

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J-P Bronowicki

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

R Esteban

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

V Sniukiene

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

M H Burroughs

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

W Deng

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

F J Dutko

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

C A Brass

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

J K Albrecht

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

26 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

16-27

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Boceprevir for previously treated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Boceprevir for untreated chronic HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Telaprevir for Retreatment of HCV Infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Effectiveness of pegylated interferon/ribavirin combination in 'real world' patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Adherence to hepatitis C virus therapy and early virologic outcomes

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12342

21 January 2018

Identifiers

10.1111/APT.12342

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42992590&oldid=1975947827"